 Steve Groshong
Concepts (314)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Idiopathic Pulmonary Fibrosis | 15 | 2023 | 623 | 1.120 |
Why?
| | Lung | 25 | 2023 | 3743 | 0.640 |
Why?
| | Lung Diseases, Interstitial | 12 | 2017 | 593 | 0.610 |
Why?
| | Lung Diseases | 3 | 2023 | 715 | 0.440 |
Why?
| | Tomography, X-Ray Computed | 11 | 2023 | 2523 | 0.430 |
Why?
| | Mucin-5B | 6 | 2018 | 217 | 0.430 |
Why?
| | Alveolitis, Extrinsic Allergic | 3 | 2023 | 92 | 0.430 |
Why?
| | Pulmonary Fibrosis | 6 | 2020 | 377 | 0.410 |
Why?
| | Biopsy | 9 | 2019 | 1081 | 0.410 |
Why?
| | Fibroblasts | 6 | 2020 | 935 | 0.330 |
Why?
| | Bleomycin | 3 | 2020 | 240 | 0.310 |
Why?
| | Interdisciplinary Communication | 1 | 2009 | 187 | 0.300 |
Why?
| | Bronchoscopy | 4 | 2018 | 207 | 0.260 |
Why?
| | Diagnosis, Differential | 9 | 2023 | 1416 | 0.250 |
Why?
| | Emergency Medical Technicians | 1 | 2006 | 37 | 0.250 |
Why?
| | Machine Learning | 3 | 2019 | 445 | 0.240 |
Why?
| | Infusions, Intravenous | 1 | 2006 | 385 | 0.230 |
Why?
| | Acute Lung Injury | 2 | 2022 | 264 | 0.230 |
Why?
| | Cysts | 2 | 2023 | 108 | 0.220 |
Why?
| | Birt-Hogg-Dube Syndrome | 1 | 2023 | 7 | 0.210 |
Why?
| | Peritoneal Neoplasms | 1 | 2004 | 87 | 0.210 |
Why?
| | Teratoma | 1 | 2004 | 103 | 0.210 |
Why?
| | Lymphangioleiomyomatosis | 1 | 2023 | 33 | 0.210 |
Why?
| | Histiocytosis, Langerhans-Cell | 1 | 2023 | 36 | 0.200 |
Why?
| | Research Report | 1 | 2022 | 73 | 0.190 |
Why?
| | Apoptosis | 4 | 2018 | 2435 | 0.180 |
Why?
| | Cough | 2 | 2015 | 116 | 0.180 |
Why?
| | Middle Aged | 31 | 2021 | 30889 | 0.180 |
Why?
| | Bronchial Diseases | 2 | 2012 | 38 | 0.170 |
Why?
| | Receptor-Like Protein Tyrosine Phosphatases, Class 4 | 1 | 2020 | 23 | 0.170 |
Why?
| | Glioma | 1 | 2004 | 353 | 0.170 |
Why?
| | Lung Neoplasms | 4 | 2018 | 2328 | 0.170 |
Why?
| | Inflammation | 5 | 2022 | 2654 | 0.170 |
Why?
| | Myofibroblasts | 2 | 2018 | 119 | 0.160 |
Why?
| | Biomarkers, Tumor | 4 | 2014 | 1181 | 0.160 |
Why?
| | Transforming Growth Factor beta | 2 | 2020 | 445 | 0.160 |
Why?
| | Phenotype | 5 | 2015 | 3044 | 0.160 |
Why?
| | Protein Tyrosine Phosphatase, Non-Receptor Type 13 | 1 | 2018 | 6 | 0.150 |
Why?
| | Common Variable Immunodeficiency | 1 | 2018 | 27 | 0.150 |
Why?
| | Ovarian Neoplasms | 1 | 2004 | 488 | 0.150 |
Why?
| | Dihematoporphyrin Ether | 1 | 2018 | 2 | 0.150 |
Why?
| | Photochemotherapy | 1 | 2018 | 32 | 0.140 |
Why?
| | Photosensitizing Agents | 1 | 2018 | 31 | 0.140 |
Why?
| | Humans | 47 | 2023 | 128417 | 0.140 |
Why?
| | Sarcoidosis, Pulmonary | 2 | 2009 | 79 | 0.140 |
Why?
| | Sequence Analysis, RNA | 2 | 2017 | 429 | 0.140 |
Why?
| | Clinical Decision-Making | 1 | 2020 | 304 | 0.140 |
Why?
| | Aged | 20 | 2021 | 21953 | 0.140 |
Why?
| | Complement C3 | 1 | 2018 | 198 | 0.140 |
Why?
| | Gene Expression Regulation | 3 | 2016 | 2505 | 0.130 |
Why?
| | HLA-DQ beta-Chains | 1 | 2016 | 61 | 0.130 |
Why?
| | fas Receptor | 2 | 2018 | 95 | 0.130 |
Why?
| | Case-Control Studies | 8 | 2018 | 3328 | 0.130 |
Why?
| | HLA-DRB1 Chains | 1 | 2016 | 108 | 0.120 |
Why?
| | Genomics | 1 | 2021 | 715 | 0.120 |
Why?
| | Adenocarcinoma | 2 | 2018 | 888 | 0.120 |
Why?
| | Genetic Loci | 2 | 2016 | 274 | 0.120 |
Why?
| | Genotype | 2 | 2018 | 1828 | 0.120 |
Why?
| | Idiopathic Interstitial Pneumonias | 1 | 2015 | 49 | 0.120 |
Why?
| | Female | 29 | 2021 | 68153 | 0.110 |
Why?
| | Male | 28 | 2021 | 62857 | 0.110 |
Why?
| | Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2014 | 56 | 0.110 |
Why?
| | Receptors, Bombesin | 1 | 2014 | 2 | 0.110 |
Why?
| | Genome-Wide Association Study | 3 | 2016 | 1336 | 0.110 |
Why?
| | Epithelial Cells | 4 | 2020 | 1032 | 0.110 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 2 | 2014 | 1045 | 0.110 |
Why?
| | Matrix Metalloproteinase 7 | 1 | 2013 | 25 | 0.110 |
Why?
| | Carcinoma, Small Cell | 1 | 2014 | 168 | 0.100 |
Why?
| | Dyspnea | 1 | 2015 | 238 | 0.100 |
Why?
| | Adult | 17 | 2023 | 35299 | 0.100 |
Why?
| | Collagen | 2 | 2012 | 429 | 0.100 |
Why?
| | Genetic Variation | 1 | 2018 | 933 | 0.100 |
Why?
| | Mucin 5AC | 1 | 2013 | 69 | 0.100 |
Why?
| | Mice | 11 | 2022 | 16602 | 0.100 |
Why?
| | E2F1 Transcription Factor | 1 | 2012 | 61 | 0.100 |
Why?
| | Bronchi | 1 | 2013 | 240 | 0.100 |
Why?
| | Immunohistochemistry | 6 | 2018 | 1664 | 0.100 |
Why?
| | Lymphatic Vessels | 1 | 2012 | 60 | 0.100 |
Why?
| | Disease Models, Animal | 5 | 2018 | 3937 | 0.100 |
Why?
| | Trachea | 1 | 2013 | 221 | 0.100 |
Why?
| | Up-Regulation | 2 | 2013 | 825 | 0.090 |
Why?
| | Cilia | 1 | 2013 | 179 | 0.090 |
Why?
| | Animals | 14 | 2022 | 34479 | 0.090 |
Why?
| | Algorithms | 1 | 2019 | 1618 | 0.090 |
Why?
| | Lipopolysaccharides | 2 | 2012 | 856 | 0.090 |
Why?
| | Chromosomes, Human, Pair 11 | 1 | 2011 | 56 | 0.090 |
Why?
| | Arthritis, Rheumatoid | 2 | 2012 | 1104 | 0.090 |
Why?
| | Genetic Markers | 3 | 2021 | 338 | 0.090 |
Why?
| | beta Carotene | 1 | 2010 | 21 | 0.090 |
Why?
| | Pulmonary Medicine | 1 | 2011 | 80 | 0.090 |
Why?
| | Peptides, Cyclic | 1 | 2012 | 255 | 0.090 |
Why?
| | Sensitivity and Specificity | 3 | 2021 | 1815 | 0.090 |
Why?
| | Polymorphism, Single Nucleotide | 3 | 2015 | 2062 | 0.090 |
Why?
| | Severity of Illness Index | 3 | 2015 | 2721 | 0.080 |
Why?
| | Hemorrhage | 1 | 2014 | 645 | 0.080 |
Why?
| | Pulmonary Alveoli | 2 | 2009 | 366 | 0.080 |
Why?
| | Serum Amyloid A Protein | 1 | 2009 | 30 | 0.080 |
Why?
| | Coronavirus, Rat | 1 | 2009 | 1 | 0.080 |
Why?
| | Virus Replication | 2 | 2009 | 444 | 0.080 |
Why?
| | Asthma | 2 | 2015 | 2213 | 0.080 |
Why?
| | Proteins | 1 | 2015 | 932 | 0.080 |
Why?
| | Salivary Glands, Minor | 1 | 2009 | 9 | 0.080 |
Why?
| | CASP8 and FADD-Like Apoptosis Regulating Protein | 1 | 2009 | 21 | 0.080 |
Why?
| | Societies, Medical | 2 | 2011 | 745 | 0.080 |
Why?
| | Gammaherpesvirinae | 1 | 2009 | 37 | 0.080 |
Why?
| | Toll-Like Receptor 2 | 1 | 2009 | 110 | 0.080 |
Why?
| | Lymphoproliferative Disorders | 1 | 2009 | 54 | 0.080 |
Why?
| | Sjogren's Syndrome | 1 | 2009 | 48 | 0.080 |
Why?
| | Immunity, Innate | 2 | 2012 | 802 | 0.080 |
Why?
| | Actinomycosis | 1 | 2008 | 3 | 0.080 |
Why?
| | Gene Expression Profiling | 5 | 2016 | 1688 | 0.080 |
Why?
| | Mycobacterium avium-intracellulare Infection | 1 | 2009 | 61 | 0.080 |
Why?
| | Prospective Studies | 6 | 2021 | 7036 | 0.080 |
Why?
| | Disease Progression | 4 | 2023 | 2602 | 0.080 |
Why?
| | Scleroderma, Limited | 1 | 2008 | 5 | 0.080 |
Why?
| | Tuberculosis, Pulmonary | 1 | 2009 | 135 | 0.080 |
Why?
| | Signal Transduction | 2 | 2020 | 4826 | 0.080 |
Why?
| | Herpesviridae Infections | 1 | 2009 | 134 | 0.070 |
Why?
| | Hypertension, Pulmonary | 2 | 2012 | 1745 | 0.070 |
Why?
| | Colitis, Ischemic | 1 | 2007 | 6 | 0.070 |
Why?
| | Granulomatosis with Polyangiitis | 1 | 2007 | 42 | 0.070 |
Why?
| | Enterocolitis, Pseudomembranous | 1 | 2007 | 26 | 0.070 |
Why?
| | Escherichia coli O157 | 1 | 2007 | 30 | 0.070 |
Why?
| | Reproducibility of Results | 3 | 2021 | 3020 | 0.070 |
Why?
| | Foreign Bodies | 1 | 2008 | 101 | 0.070 |
Why?
| | Neoplasm Proteins | 1 | 2010 | 421 | 0.070 |
Why?
| | Pneumonia | 2 | 2009 | 598 | 0.070 |
Why?
| | Autoantibodies | 2 | 2012 | 1463 | 0.070 |
Why?
| | Diagnostic Imaging | 1 | 2009 | 330 | 0.070 |
Why?
| | Escherichia coli Infections | 1 | 2007 | 105 | 0.070 |
Why?
| | Cells, Cultured | 4 | 2020 | 4001 | 0.070 |
Why?
| | Pulmonary Artery | 1 | 2012 | 1030 | 0.060 |
Why?
| | Dietary Supplements | 1 | 2010 | 531 | 0.060 |
Why?
| | Missouri | 1 | 2006 | 68 | 0.060 |
Why?
| | Interferon-gamma | 1 | 2009 | 759 | 0.060 |
Why?
| | Aged, 80 and over | 5 | 2021 | 7033 | 0.060 |
Why?
| | Ambulances | 1 | 2006 | 50 | 0.060 |
Why?
| | Mice, Knockout | 3 | 2018 | 2755 | 0.060 |
Why?
| | Promoter Regions, Genetic | 3 | 2018 | 1198 | 0.060 |
Why?
| | Coronavirus Infections | 1 | 2009 | 337 | 0.060 |
Why?
| | Gene Expression | 3 | 2017 | 1456 | 0.060 |
Why?
| | Retinoblastoma Protein | 1 | 2004 | 54 | 0.060 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2009 | 1185 | 0.060 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2004 | 69 | 0.060 |
Why?
| | alpha-Fetoproteins | 1 | 2004 | 39 | 0.060 |
Why?
| | B-Lymphocytes | 1 | 2009 | 817 | 0.050 |
Why?
| | Biopsy, Needle | 2 | 2018 | 188 | 0.050 |
Why?
| | Hysterectomy | 1 | 2004 | 118 | 0.050 |
Why?
| | Double-Blind Method | 2 | 2023 | 1848 | 0.050 |
Why?
| | Linkage Disequilibrium | 2 | 2016 | 256 | 0.050 |
Why?
| | Smoking | 1 | 2010 | 1460 | 0.050 |
Why?
| | Gene Frequency | 2 | 2015 | 504 | 0.050 |
Why?
| | Vital Capacity | 1 | 2023 | 288 | 0.050 |
Why?
| | Predictive Value of Tests | 2 | 2019 | 1935 | 0.050 |
Why?
| | Cohort Studies | 4 | 2017 | 5388 | 0.050 |
Why?
| | Pyridones | 1 | 2023 | 159 | 0.050 |
Why?
| | Uterine Cervical Neoplasms | 1 | 2004 | 232 | 0.050 |
Why?
| | Genetic Predisposition to Disease | 3 | 2016 | 2264 | 0.040 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2013 | 756 | 0.040 |
Why?
| | Interleukin-10 | 2 | 2014 | 299 | 0.040 |
Why?
| | Fibrosis | 1 | 2022 | 512 | 0.040 |
Why?
| | Respiratory Function Tests | 2 | 2012 | 580 | 0.040 |
Why?
| | Emergency Medical Services | 1 | 2006 | 518 | 0.040 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2004 | 620 | 0.040 |
Why?
| | Retrospective Studies | 6 | 2014 | 14454 | 0.040 |
Why?
| | Kaplan-Meier Estimate | 2 | 2014 | 853 | 0.040 |
Why?
| | Macrophages, Alveolar | 2 | 2014 | 376 | 0.040 |
Why?
| | Drug Resistance, Microbial | 1 | 2018 | 64 | 0.040 |
Why?
| | Tissue Culture Techniques | 1 | 2018 | 68 | 0.040 |
Why?
| | Chronic Disease | 2 | 2018 | 1705 | 0.040 |
Why?
| | A549 Cells | 1 | 2018 | 58 | 0.040 |
Why?
| | Rats | 3 | 2011 | 5165 | 0.040 |
Why?
| | Reference Values | 1 | 2018 | 776 | 0.030 |
Why?
| | Dogs | 1 | 2018 | 366 | 0.030 |
Why?
| | Antiviral Agents | 1 | 2022 | 703 | 0.030 |
Why?
| | Occupational Exposure | 1 | 2020 | 310 | 0.030 |
Why?
| | Mice, Inbred C57BL | 2 | 2020 | 5272 | 0.030 |
Why?
| | RNA, Small Interfering | 1 | 2018 | 571 | 0.030 |
Why?
| | Pneumonectomy | 1 | 2018 | 150 | 0.030 |
Why?
| | Chromosomes, Human, Pair 6 | 1 | 2016 | 51 | 0.030 |
Why?
| | Down-Regulation | 1 | 2018 | 631 | 0.030 |
Why?
| | ROC Curve | 1 | 2017 | 500 | 0.030 |
Why?
| | ADAMTS9 Protein | 1 | 2015 | 6 | 0.030 |
Why?
| | Serpin E2 | 1 | 2015 | 6 | 0.030 |
Why?
| | Procollagen N-Endopeptidase | 1 | 2015 | 8 | 0.030 |
Why?
| | ADAMTS4 Protein | 1 | 2015 | 15 | 0.030 |
Why?
| | E-Selectin | 1 | 2015 | 53 | 0.030 |
Why?
| | Receptor for Advanced Glycation End Products | 1 | 2015 | 30 | 0.030 |
Why?
| | Phosphorylation | 1 | 2020 | 1681 | 0.030 |
Why?
| | Serpins | 1 | 2015 | 31 | 0.030 |
Why?
| | Flow Cytometry | 2 | 2009 | 1142 | 0.030 |
Why?
| | ADAM Proteins | 1 | 2015 | 58 | 0.030 |
Why?
| | NF-kappa B | 2 | 2009 | 649 | 0.030 |
Why?
| | Breast Neoplasms | 1 | 2007 | 2132 | 0.030 |
Why?
| | Auscultation | 1 | 2015 | 4 | 0.030 |
Why?
| | Herpesviridae | 1 | 2015 | 22 | 0.030 |
Why?
| | Bronchoalveolar Lavage | 1 | 2015 | 89 | 0.030 |
Why?
| | Hemosiderin | 1 | 2014 | 2 | 0.030 |
Why?
| | Pandemics | 1 | 2023 | 1476 | 0.030 |
Why?
| | Neutrophils | 2 | 2011 | 1193 | 0.030 |
Why?
| | Bleeding Time | 1 | 2014 | 7 | 0.030 |
Why?
| | Neoplasms | 1 | 2009 | 2464 | 0.030 |
Why?
| | Cell Line | 2 | 2011 | 2731 | 0.030 |
Why?
| | Asymptomatic Diseases | 1 | 2015 | 84 | 0.030 |
Why?
| | Integrin alpha6 | 1 | 2013 | 9 | 0.030 |
Why?
| | Tetraspanin 24 | 1 | 2013 | 7 | 0.030 |
Why?
| | Cell Proliferation | 2 | 2013 | 2344 | 0.030 |
Why?
| | Radiography, Thoracic | 1 | 2015 | 164 | 0.030 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2015 | 257 | 0.030 |
Why?
| | Fibrin | 1 | 2014 | 68 | 0.030 |
Why?
| | Thromboplastin | 1 | 2013 | 69 | 0.030 |
Why?
| | Mice, Inbred Strains | 1 | 2014 | 402 | 0.030 |
Why?
| | Clone Cells | 1 | 2013 | 255 | 0.030 |
Why?
| | Chromosomes, Human | 1 | 2013 | 41 | 0.030 |
Why?
| | Keratins | 1 | 2013 | 175 | 0.030 |
Why?
| | Vascular Endothelial Growth Factor D | 1 | 2012 | 12 | 0.030 |
Why?
| | Aldehyde Dehydrogenase | 1 | 2013 | 105 | 0.030 |
Why?
| | Vascular Endothelial Growth Factor C | 1 | 2012 | 15 | 0.030 |
Why?
| | Lymphangiogenesis | 1 | 2012 | 25 | 0.030 |
Why?
| | DNA, Viral | 1 | 2015 | 348 | 0.030 |
Why?
| | Young Adult | 3 | 2017 | 12312 | 0.030 |
Why?
| | Treatment Outcome | 2 | 2023 | 10151 | 0.030 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2015 | 431 | 0.030 |
Why?
| | Logistic Models | 1 | 2017 | 1974 | 0.020 |
Why?
| | Mice, 129 Strain | 1 | 2012 | 79 | 0.020 |
Why?
| | Blood Coagulation Factors | 1 | 2012 | 47 | 0.020 |
Why?
| | Alveolar Epithelial Cells | 1 | 2013 | 97 | 0.020 |
Why?
| | Regeneration | 1 | 2013 | 174 | 0.020 |
Why?
| | Airway Remodeling | 1 | 2012 | 58 | 0.020 |
Why?
| | Polymorphism, Genetic | 1 | 2015 | 639 | 0.020 |
Why?
| | Epoprostenol | 1 | 2012 | 134 | 0.020 |
Why?
| | Pulmonary Eosinophilia | 1 | 2011 | 26 | 0.020 |
Why?
| | Fas Ligand Protein | 1 | 2011 | 59 | 0.020 |
Why?
| | Microscopy, Fluorescence | 1 | 2013 | 399 | 0.020 |
Why?
| | Connective Tissue Diseases | 1 | 2012 | 81 | 0.020 |
Why?
| | Sex Distribution | 1 | 2012 | 358 | 0.020 |
Why?
| | Cell Line, Transformed | 1 | 2011 | 140 | 0.020 |
Why?
| | Cocarcinogenesis | 1 | 2010 | 14 | 0.020 |
Why?
| | Cytochromes | 1 | 2010 | 10 | 0.020 |
Why?
| | Proportional Hazards Models | 1 | 2014 | 1196 | 0.020 |
Why?
| | Genetic Linkage | 1 | 2011 | 299 | 0.020 |
Why?
| | Neovascularization, Pathologic | 1 | 2012 | 290 | 0.020 |
Why?
| | Respiratory Mucosa | 1 | 2013 | 304 | 0.020 |
Why?
| | alpha-Tocopherol | 1 | 2010 | 32 | 0.020 |
Why?
| | Cyclin D1 | 1 | 2010 | 63 | 0.020 |
Why?
| | Endotoxins | 1 | 2011 | 216 | 0.020 |
Why?
| | Spleen | 1 | 2012 | 507 | 0.020 |
Why?
| | Receptors, Retinoic Acid | 1 | 2010 | 51 | 0.020 |
Why?
| | Radiography | 1 | 2012 | 859 | 0.020 |
Why?
| | Sequence Analysis, DNA | 1 | 2013 | 771 | 0.020 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2012 | 500 | 0.020 |
Why?
| | Homeostasis | 1 | 2013 | 603 | 0.020 |
Why?
| | Ki-67 Antigen | 1 | 2010 | 107 | 0.020 |
Why?
| | Purpura | 1 | 2009 | 14 | 0.020 |
Why?
| | Receptors, Tumor Necrosis Factor, Type II | 1 | 2009 | 42 | 0.020 |
Why?
| | Bacterial Infections | 1 | 2011 | 226 | 0.020 |
Why?
| | Receptors, Tumor Necrosis Factor, Type I | 1 | 2009 | 83 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2012 | 1269 | 0.020 |
Why?
| | Granuloma | 1 | 2009 | 84 | 0.020 |
Why?
| | Rats, Inbred F344 | 1 | 2009 | 251 | 0.020 |
Why?
| | Elastin | 1 | 2009 | 77 | 0.020 |
Why?
| | Multicenter Studies as Topic | 1 | 2010 | 285 | 0.020 |
Why?
| | Binding Sites | 1 | 2012 | 1236 | 0.020 |
Why?
| | Gastroesophageal Reflux | 1 | 2011 | 229 | 0.020 |
Why?
| | Pulmonary Surfactants | 1 | 2009 | 105 | 0.020 |
Why?
| | Thrombosis | 1 | 2012 | 324 | 0.020 |
Why?
| | Myoblasts | 1 | 2009 | 80 | 0.020 |
Why?
| | DNA Topoisomerases, Type I | 1 | 2008 | 15 | 0.020 |
Why?
| | Antihypertensive Agents | 1 | 2012 | 485 | 0.020 |
Why?
| | Testicular Neoplasms | 1 | 2009 | 102 | 0.020 |
Why?
| | Adolescent | 3 | 2017 | 20179 | 0.020 |
Why?
| | Leukocytes | 1 | 2009 | 303 | 0.020 |
Why?
| | Fatal Outcome | 1 | 2008 | 300 | 0.020 |
Why?
| | Hepatitis C, Chronic | 1 | 2009 | 152 | 0.020 |
Why?
| | Phagocytosis | 1 | 2009 | 362 | 0.020 |
Why?
| | Precision Medicine | 1 | 2011 | 384 | 0.020 |
Why?
| | Pulmonary Circulation | 1 | 2009 | 416 | 0.020 |
Why?
| | Lymphocytes | 1 | 2009 | 367 | 0.020 |
Why?
| | Transcriptome | 1 | 2013 | 881 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 815 | 0.020 |
Why?
| | Survival Analysis | 1 | 2010 | 1263 | 0.020 |
Why?
| | Transfection | 1 | 2009 | 893 | 0.020 |
Why?
| | RNA | 1 | 2013 | 880 | 0.020 |
Why?
| | Anastomosis, Surgical | 1 | 2007 | 149 | 0.020 |
Why?
| | Photomicrography | 1 | 2006 | 7 | 0.020 |
Why?
| | Colectomy | 1 | 2007 | 93 | 0.020 |
Why?
| | Respiratory Insufficiency | 1 | 2010 | 313 | 0.020 |
Why?
| | Rare Diseases | 1 | 2007 | 101 | 0.020 |
Why?
| | Mice, Inbred BALB C | 1 | 2009 | 1228 | 0.020 |
Why?
| | Polymerase Chain Reaction | 1 | 2009 | 1020 | 0.020 |
Why?
| | Risk Factors | 1 | 2020 | 9704 | 0.020 |
Why?
| | Cell Differentiation | 1 | 2013 | 1900 | 0.020 |
Why?
| | Abdominal Pain | 1 | 2007 | 145 | 0.020 |
Why?
| | Lung Transplantation | 1 | 2008 | 276 | 0.020 |
Why?
| | Acute Disease | 1 | 2008 | 964 | 0.020 |
Why?
| | MicroRNAs | 1 | 2012 | 677 | 0.020 |
Why?
| | Interleukin-6 | 1 | 2009 | 716 | 0.020 |
Why?
| | Base Sequence | 1 | 2009 | 2135 | 0.020 |
Why?
| | Colonoscopy | 1 | 2007 | 234 | 0.010 |
Why?
| | In Vitro Techniques | 1 | 2006 | 1039 | 0.010 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2010 | 1356 | 0.010 |
Why?
| | Weight Loss | 1 | 2009 | 725 | 0.010 |
Why?
| | Uterine Cervical Dysplasia | 1 | 2004 | 43 | 0.010 |
Why?
| | Longitudinal Studies | 1 | 2011 | 2710 | 0.010 |
Why?
| | Liver | 1 | 2012 | 1826 | 0.010 |
Why?
| | Biomarkers | 1 | 2015 | 3880 | 0.010 |
Why?
| | Nuclear Proteins | 1 | 2008 | 657 | 0.010 |
Why?
| | Intestinal Mucosa | 1 | 2007 | 575 | 0.010 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2006 | 735 | 0.010 |
Why?
| | RNA, Messenger | 1 | 2009 | 2675 | 0.010 |
Why?
| | Cytokines | 1 | 2009 | 1983 | 0.010 |
Why?
| | Mutation | 1 | 2011 | 3689 | 0.010 |
Why?
| | Follow-Up Studies | 1 | 2007 | 4892 | 0.010 |
Why?
| | United States | 1 | 2011 | 13830 | 0.010 |
Why?
|
|
Groshong's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|